Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches.

Philip Roland SelbyMorgyn S WarnerSandra L PeakePeter BardyDevendra HiwaseDeepak SinghalAshanka BeligaswatteUwe HahnJason A RobertsDavid YeungSepehr Shakib

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2022)

The antifungal prophylaxis pathway used in cohort 2 resulted in reduced antifungal-associated adverse effects, less patients requiring progression to 3rd and 4th line prophylaxis and reduced antifungal drug costs.

Keyphrases

stem cell transplantation
candida albicans
high dose
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
emergency department
low dose
patient reported outcomes
adverse drug
drug induced
patient reported